Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

completed360%
unknown120%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
unknown

Comparison of Vitrification Effect Before or After In Vitro Maturation

NCT03416400
completednot_applicable

Egg Freezing Pilot Study

NCT00839839
completednot_applicable

IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing

NCT02026193
completedphase_4

Embryo Developmental Capacity After Egg Banking in an Ovum Donation Program

NCT00977821
terminatednot_applicable

Fertility Preservation in Female Cancer Patients

NCT01268592

Clinical Trials (5)

Showing 5 of 5 trials
NCT03416400

Comparison of Vitrification Effect Before or After In Vitro Maturation

Unknown
NCT00839839Not Applicable

Egg Freezing Pilot Study

Completed
NCT02026193Not Applicable

IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing

Completed
NCT00977821Phase 4

Embryo Developmental Capacity After Egg Banking in an Ovum Donation Program

Completed
NCT01268592Not Applicable

Fertility Preservation in Female Cancer Patients

Terminated

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5